CCM
AQST icon

Cox Capital Management’s Aquestive Therapeutics AQST Stock Holding History

Cox Capital Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.7K Hold
10,500
– – 0.02% 81
2026
Q1 		$43.6K Hold
10,500
– – 0.03% 73
2025
Q4 		$35.9K Hold
10,500
– – 0.02% 62
2025
Q3 		$58.7K Buy
+10,500
New +$45.4K 0.04% 61

Other funds holding AQST

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
SMAM
Sugar Maple Asset Management Sister Bay, Wisconsin $155M AUM 17.72% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return
SWRP
Summit Wealth & Retirement Planning San Ramon, California $472M AUM 25.49% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Cox Capital Management's AQST Position: Q2 2026 in Review

Cox Capital Management held its Aquestive Therapeutics (AQST) position steady in Q2 2026 at 10,500 shares worth $43.7K. The position accounts for 0.02% of the portfolio, ranked #81.

Cox Capital Management first reported a position in AQST in Q3 2025 and has held it in 4 quarters since. The position peaked at $58.7K in Q3 2025. 34 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Cox Capital Management held 10,500 shares of Aquestive Therapeutics worth $43.7K as of Q2 2026.
  • Cox Capital Management left its Aquestive Therapeutics share count unchanged in Q2 2026.
  • Aquestive Therapeutics made up 0.02% of Cox Capital Management's portfolio in Q2 2026, its #81 holding.
  • Cox Capital Management first reported a position in Aquestive Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Cox Capital Management's Aquestive Therapeutics position peaked at $58.7K in Q3 2025.
  • 34 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Cox Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.